Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02667015 · ClinicalTrials.gov registry record · Phase 2
Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity
A Phase 2 study, sponsored by Hartford Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 41
- Enrollment target
NCT02667015 is a Phase 2 study that has completed, run by Hartford Hospital. The registered enrollment target is 41 participants.
The verdict
NCT02667015, a Phase 2 study, has completed, sponsored by Hartford Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 41 participants
- Enrollment target
Study Summary
The aim of the current study is to develop and pilot test an anxiety sensitivity-based intervention for co-occurring substance use disorders (SUDs) and anxiety. Research questions include determining whether a broadly-applicable AS-based intervention can significantly decrease both substance misuse and anxiety. Secondary aims include examining the impact of this intervention on general functioning and depressive/anxious symptoms. In phase I, an initial pilot was conducted to examine the feasibility, safety, and patient satisfaction with the protocol, and to estimate potential efficacy of the protocol. In phase II, participants will be randomized to the intervention or a control condition.
Interventions
- BEHAVIORAL Psychotherapy (Anxiety Sensitivity Intervention)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02667015
The ClinicalTrials.gov registry entry for NCT02667015 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hartford Hospital, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Psychotherapy (Anxiety Sensitivity Intervention) is the first listed.
NCT02667015 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02667015 about?
NCT02667015 is a clinical study titled "Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity". The aim of the current study is to develop and pilot test an anxiety sensitivity-based intervention for co-occurring substance use disorders (SUDs) and anxiety. Research questions include determining whether a broadly-applicable AS-based intervention can significantly decrease both substance misuse ...
What is the current status of trial NCT02667015?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 41 participants. The study started on 2012-05. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02667015?
The interventions under investigation include: Psychotherapy (Anxiety Sensitivity Intervention) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02667015?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.